Inspired by Paulo Nuin, I thought it would be a good idea for the last post of the year before the Christmas holidays to be a list; the good, the bad and the ugly.
Best of the best
HBA and SCIP Memberships
Buying a 2 GB flash drive and then picking up 2 free ones at ASCO a week later, doh!
Best New Technology
Discovering the Cloud – who needs desktop apps?
Evernote Premium Upgrade – it's a great web 2.0 database for storing snippets and clips of data
MS Office for Mac – it garbled scientific symbols in large files
Best left unsaid
Best Scientific Meeting
Worst Scientific Meeting
ASH – usually my favourite, but this year it got too big and too full of non-cancer topics
Best Cancer Data
Triple and quadruple induction therapy with Vel/Rev/Dex/Pred led to 100% response rates and survival not yet defined after 8 months. Some patients were still in remission after 2 years.
Best Non-Cancer data by an oncology drug
Gleevec (imatinib) may be effective in Type I diabetes.
Worst Cancer Data
Any drug that fails is a disappointment, as are yet more 'me-too-not-very-effective' chemotherapies such as toiposomerase inhibitors.
Best new cancer drug in development
Abiraterone from Cougar Biotech
What categories would you have for your list? Do tell.